Clinical studies recruiting near Shanghai

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
NA · Renji Hospital Affiliated to Shanghai Jiao Tong University · Second Affiliated Hospital, Zhejiang University, School of M · NCT04078230 A Study of GC203 TIL in PDCA (RJ)
EARLY_Phase 1 · Ruijin Hospital · Shanghai Juncell Therapeutics · NCT06828328 Carbon Ion Therapy for Peripheral Non-small Cell Lung Cancer
Phase 2 · Shanghai Proton and Heavy Ion Center · Shanghai Proton and Heavy Ion Center · NCT05613452 Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Targ
Phase 2 · Fudan University · Fudan University · NCT06841159 Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents
Phase 2/Phase 3 · Shanghai Children's Medical Center · Children's Cancer Group, China · NCT07168980 Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUre
Phase 3 · Shuguang Hospital Affiliated to Shanghai University of Tradi · Tasly Pharmaceutical Group Co., Ltd · NCT07687186 A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · Shanghai Jiao Tong University School of Medicine, Renji Hosp · R1 Therapeutics · NCT06712654 A Study to Evaluate 9MW2821 Versus Treatment of Physician's Choice for Subjects With Recurrent or Metastatic Cervical Ca
Phase 3 · Fudan University Shanghai Cancer Center · Mabwell (Shanghai) Bioscience Co., Ltd. · NCT06692166 FUSCC Refractory TNBC Platform Study (FUTURE2.0)
Phase 2 · Fudan University Shanghai Cancer Center · Fudan University · NCT05749588 A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Renji Hospital Shanghai Jiao Tong University School of Medic · Eli Lilly and Company · NCT07218380 Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic On
Phase 2 · Fudan University Cancer Center · Fudan University · NCT05281003 Cellular Immunotherapy for Relapsed or Refractory Lymphoma Data Collection
Phase N/A · Department of Hematology, Shanghai Institute of Hematology, · Ruijin Hospital · NCT06541327 REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translati
Phase 1/Phase 2 · Ruijin Hospital affiliated to Shanghai Jiao Tong University · Ruijin Hospital · NCT06946953 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-56001, Shanghai, Shanghai · Colorado Prevention Center · NCT06024746 Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
Phase 1/Phase 2 · Fudan University Shanghai Cancer Center · Sichuan Enray Pharmaceutical Sciences Company · NCT07433283 A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Investigational Site Number : 1560005 · Sanofi · NCT06867094 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Fudan University Shanghai Cancer Center · Pfizer · NCT07028853 IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer
Phase 1/Phase 2 · Renji Hospital of Shanghai Jiaotong University School of Med · InxMed (Shanghai) Co., Ltd. · NCT05827796 Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Shanghai First Maternity and Infant HospitalShanghai First M · Daiichi Sankyo · NCT07022483 Primary Aldosteronism: Prospective Screening Registry in China
Phase N/A · Shanghai Institite of Hypertension, Ruijin Hospital, Shangha · Shanghai Jiao Tong University School of Medicine · NCT04020783 Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies
Phase 2 · Blood & Marrow Transplantation Center, RuiJin Hospital · Shanghai Jiao Tong University School of Medicine · NCT05436561 Cell Free DNA in Mature B-cell Lymphoma
Phase N/A · Ruijin hospital · Ruijin Hospital · NCT04088422 Coronary Aspiration Catheter Clinical Trial
NA · Zhongshan Hospital, Fudan University · BrosMed Medical Co., Ltd · NCT06951724 Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC
NA · Cancer hospital Fudan University · Fudan University · NCT06258642 Lymphocyte-sparing Thoracic Radiotherapy for Esophageal Squamous Cell Carcinoma
NA · Ruijin hospital, Shanghai jiaotong university school of medi · Ruijin Hospital · NCT06596954 A Study of BL-B01D1 in Combination With Osimertinib Mesylate Tablets in Patients With Locally Advanced or Metastatic Non
Phase 2 · Shanghai East Hospital · Sichuan Baili Pharmaceutical Co., Ltd. · NCT06498986 A Study of ASKG915 in Patients With Selected Advanced Solid Tumors.
Phase 1/Phase 2 · Fudan University Shanghai Cancer Center · AskGene Pharma, Inc. · NCT05867420 Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis
NA · Changhai Hospital · Changhai Hospital · NCT07074379 Phase II Study of Serplulimab Combined with First-Line Targeted Therapy, Chemotherapy, and Radiation in Advanced Colorec
Phase 2 · Fudan University Shanghai Cancer Center · Fudan University · NCT06521866 A Multicenter, Non-interventional, Descriptive Study to Assess Assay Concordance of HER2 IHC Testing in Chinese Pan-tumo
Phase N/A · Research Site · AstraZeneca · NCT07404202

Look up another city

Look up another condition